- Home
- BNR vs BLUE Comparison
BNR vs BLUE Comparison
Compare BNR & BLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- BLUE
- Stock Information
- Founded
- BNR 2014
- BLUE 1992
- Country
- BNR China
- BLUE United States
- Employees
- BNR N/A
- BLUE N/A
- Industry
- BNR Medical Specialities
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BNR Health Care
- BLUE Health Care
- Exchange
- BNR Nasdaq
- BLUE Nasdaq
- Market Cap
- BNR 72.4M
- BLUE 82.2M
- IPO Year
- BNR 2020
- BLUE 2013
- Fundamental
- Price
- BNR $7.32
- BLUE $7.80
- Analyst Decision
- BNR
- BLUE Hold
- Analyst Count
- BNR 0
- BLUE 9
- Target Price
- BNR N/A
- BLUE $49.14
- AVG Volume (30 Days)
- BNR 5.5K
- BLUE 222.9K
- Earning Date
- BNR 12-03-2024
- BLUE 11-14-2024
- Dividend Yield
- BNR N/A
- BLUE N/A
- EPS Growth
- BNR N/A
- BLUE N/A
- EPS
- BNR N/A
- BLUE N/A
- Revenue
- BNR $72,832,704.00
- BLUE $53,120,000.00
- Revenue This Year
- BNR $52.90
- BLUE $145.88
- Revenue Next Year
- BNR $48.35
- BLUE $239.89
- P/E Ratio
- BNR N/A
- BLUE N/A
- Revenue Growth
- BNR N/A
- BLUE 144.50
- 52 Week Low
- BNR $2.62
- BLUE $5.80
- 52 Week High
- BNR $9.50
- BLUE $38.40
- Technical
- Relative Strength Index (RSI)
- BNR 63.72
- BLUE 45.52
- Support Level
- BNR $6.68
- BLUE $7.43
- Resistance Level
- BNR $7.32
- BLUE $8.75
- Average True Range (ATR)
- BNR 0.23
- BLUE 0.64
- MACD
- BNR -0.04
- BLUE -0.10
- Stochastic Oscillator
- BNR 93.63
- BLUE 12.98
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.